•Third-quarter revenue was $69 million, up 52.5% year over year, and included a one-time $14 million payment; excluding it, revenue was $55 million, up 21.6%.
•Newsmax reported net income of $15.2 million, or $0.12 per share, compared with a loss of $4.1 million, or $0.03 per share, a year earlier.
•Adjusted EBITDA was $19 million, compared with a loss of $0.9 million a year earlier, and fell to $5 million excluding the nonrecurring payment.
•Warren and Coons requested written confirmation by November 17 that instructions had been issued to preserve records on Nvidia’s chip exports to China.
•The Senate letter said Megaspeed had bought more than $4.8 billion worth of advanced Nvidia chips since June 2024.
•Nvidia shares fell 5.3% by 10:30 a.m. Eastern time on November 12.
•STERIS priced the 2033 bonds at a yield of 5.687% and a spread of 92 basis points, and the 2036 bonds at a yield of 5.894% and a spread of 102 basis points.
•The purchase price for Xodus Medical is about $2.1 billion in cash, with potential additional consideration of up to $150 million.
•STERIS expects to add about $2.0 billion of debt to finance the acquisition, following outstanding debt of about $1.9 billion on September 30, 2026.
•Sempra estimated the deal’s gross base price at about $9.99 billion.
•The consideration includes $4.65 billion in cash at closing, $4.14 billion through an interest-bearing instrument, and $1.20 billion in notes.
•The company estimated a pretax gain of between $2.80 billion and $3.30 billion and an after-tax gain of between $2.00 billion and $2.40 billion, before post-closing adjustments.
